Improving Hispanic/Latino participation in preclinical Alzheimers disease Trials
Improving Hispanic/Latino participation in preclinical Alzheimers disease Trials
批准号:
10675570
负责人:
Christian R Salazar
金额:
$13.71万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-03 至 2027-07-31
关键词:
Active LearningAddressAdultAdverse eventAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAttitudeBehavior TherapyBehavioralBeliefBiological MarkersCaliforniaClinical ResearchCognitiveCommunitiesDataDecision MakingDedicationsDisparityElderlyEnrollmentEnsureEpidemiologistEthnic OriginFellowshipFoundationsFundingGoalsGrantHealthHealth Disparities ResearchHealthcare SystemsHispanicHispanic PopulationsIndividualInfrastructureInstructionIntentionInternetInterventionK-Series Research Career ProgramsKnowledgeLatinoLatino PopulationLeadershipLinguisticsLiteratureMentorsMentorshipMethodsMinority RecruitmentModelingMulticenter StudiesMulticenter TrialsNot Hispanic or LatinoParticipantPersonsPopulationPositioning AttributeProcessRaceRandomizedRecommendationRegistriesResearchResearch PersonnelResourcesSafetySamplingScienceScientistSolidSurveysTestingTrainingTreatment EfficacyUnderrepresented PopulationsUnderserved PopulationUnited States National Institutes of HealthUniversity resourcesWorkclinical trial recruitmentcognitive interviewcommunity based researchcontextual factorsdesignevidence baseexperiencehealth literacyimprovedinnovationinsightintervention mappingliteracynovelpilot testpopulation basedpre-clinicalpreclinical trialrandomized, clinical trialsrecruitrecruitment sciencerisk perceptionskillstherapy designtreatment effectwillingness
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Despite longstanding efforts to improve recruitment of minorities into Alzheimer’s Disease and Related
Dementias (ADRD) research, US Hispanics/Latinos continue to be severely underrepresented in ADRD
randomized clinical trials. Greater representation of Hispanics/Latinos is critical to ensure the safety and efficacy
of interventions and the generalizability of results across an increasingly diverse US population. Preclinical AD
trials will be essential in the pursuit of improved ADRD therapies and are unique in requiring asymptomatic
individuals to undergo biomarker testing and to enroll with a study partner. It is unclear, however, whether these
unique requirements pose a specific challenge to the recruitment of Hispanics/Latinos into preclinical AD trials.
It is imperative that we discover and test novel interventions to improve recruitment of Hispanics/Latinos to these
trials. Given my background as an epidemiologist with a solid foundation in health disparities research, I have
the dedication for undertaking this research. Through this K01 Mentored Research Scientist Career Development
Award, I propose to receive the necessary training and research experience to address several gaps and become
a leader in ADRD recruitment science. My overarching hypothesis is that older Hispanics/Latinos are less willing
than their Non-Hispanic (NHW) counterparts to participate in preclinical AD trials, due in part to modifiable
behavioral factors amenable to intervention. To test this hypothesis, I propose three specific research aims: (1)
First, I will examine differences in willingness to participate in preclinical AD trials between diverse
Hispanics/Latinos and Non-Hispanic whites (NHW) from a national population-based sample of 1,800 older
adults who respond to a web panel survey. (2) Next, through in-person cognitive interviews, I will identify key
behavioral determinants of intention to participation in a sample of 100 local community dwelling older
Hispanics/Latinos, with a particular focus on contextual factors, cultural beliefs/values, research literacy, previous
experiences with the healthcare system, research attitudes and perceived need/benefit. (3) Lastly, I will use an
Intervention Mapping planning approach to systematically develop and pilot test a behavioral intervention that is
culturally and linguistically appropriate and designed to improve Hispanic/Latino participation in AD preclinical
trials. Findings will provide preliminary data for a large multicenter trial to test the intervention using a randomized
approach. To accomplish these aims and my goal of becoming an independent investigator, I propose to engage
in extensive ADRD training through didactic instruction, experiential learning and mentorship by the leaders in
the field. I will leverage resources from the University of California, Irvine Alzheimer’s Disease Research Center
to (a) acquire foundational knowledge of core principles in ADRD research, (b) gain experience in mixed-
methods approaches in recruitment science, (c) become proficient in designing behavioral interventions, and (d)
develop the leadership skills necessary to conduct multicenter studies and propel my research forward.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Hispanic/Latino participation in preclinical Alzheimers disease Trials
-
批准号:10426699
-
项目类别:
-
资助金额:$13.71万
-
财政年份:2022
-
负责人:Christian R Salazar
-
依托单位:
海外基金